2: RA/Gout/Movement (Part 1) Flashcards

1
Q

DMARDs were formerly considered….

Disease-modifying antirheumatic drugs

A

toxic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

only symptomatic treatment for RA

A

NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is function of DMARDS

A

Some may slow progression of RA; effects not seen for weeks or months, i.e., slow-acting.

Different mechanism than NSAIDS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what can gold be used for

A

anti-rheumatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

gold mechanism of action

A

unknown

  • may alter macrophage function & morphology
  • selectively accumulate in macrophages in the inflamed synovium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

plasma half life of Gold

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

gold tissue binding

A

avidly binds to tissues (found in liver and skin several years after therapy is DC’d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is gold excreted

A

urine and feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what gold salt is available as parenteral preparation for IM administration

A

gold sodium thiomalate (Myochrysine) – not in US, but available in Canada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

orally effective gold preparation

A

auranofin (ridaura)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most common side effect with gold

A

dermatitis (pruritus reaction is warning signal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what reactions are also common with gold use

A

mucous membrane reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what other effects are observed with the use of Gold

A

Stomatitis and ulcers on buccal membranes and tongue are observed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

skin toxicities with gold cause…

A

a bluish-gray pigmentation (chrysiasis); effects are seen in 15-20% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

serious toxicities of gold use include (2)

A

bone marrow depression (blood counts mandatory)

renal reactions such as nephrotic syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what gold is better tolerated but causes a higher incidence of GI disturbances

A

auranofin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hydroxychloroquine mechanism of action

A

Unknown, but effects may be, in part, to stabilize lysosomal membranes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

use of hydroxychloroquine used as an anti-inflammatory agent requires…

A

large doses for long periods of time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

hydroxychloroquine may cause what ocular effects

A

cause serious damage to the retina where the drug is preferentially concentrated

The retinal damage may be irreversible and may progress after the drug is discontinued.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what other effects can hydroxychloroquine cause

A

dermatitis, ototoxicity, and neuromyopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what kind of medication is D-Penicillamine (Cuprimine)

A

chelator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

mechanism of action of D-Penicillamine

A

unknown, but may affect immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how does D-Penicillamine work

A

dermatitis, ototoxicity, and neuromyopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

side effects with use of D-penicillamine

A
  • loss of taste perception
  • nephrotoxicity
  • myasthenia-like syndrome
  • rash
  • thrombocytopenia and leukopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what kind of drugs are azathioprine and methotraxate

A

cytotoxic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

cytotoxic drugs mechanism of action

A

possible direct anti-inflammatory + suppress/modify immune responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what are the very serious side effects that can be caused by azathioprine and methotrexate

A

bone marrow depression, sterility, and carcinogenic and mutagenic effects.

***In spite of these effects, aggressive early treatment with methotrexate can prevent major manifestations of RA before irreversible damage becomes prevalent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Recent clinical studies have shown that of all of DMARDS, ____________ has the best benefit-to-risk ratio.

A

methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

how is methotrexate used

A

ONCE A WEEK in very small doses (“low-dose pulse therapy”).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

mucosal ulcers are common with?

A

methotrexate use once a week in very small doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

function of TNF blockers

A

Proteins that block TNF (Tumor Necrosis Factor) which is a large group of cytokines, at it’s receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

TNF is responsible for…

A

triggering immune response and is present in larger amounts in patients with RA and some other immune disorders such as ankylosing spondylitis and psoriasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

TNF increases

A

body inflammatory reaction

34
Q

increased risk of infections with TNF blockers is due to

A

inhibited immune function

35
Q

side effects of TNF blockers

A
  • occasional fatal blood dyscrasias
  • nervous system disorders
  • seizures
  • increased risk of some cancers (ie lymphoma).
36
Q

JAK1, JAK2, JAK3 are enzymes that

A

play a part in the signaling pathways started by cytokines at their receptors

37
Q

inhibition of JAK enzymes block….

A

cytokine signaling

and can decrease various immune and inflammatory responses

38
Q

a JAK1/JAK2 inhibitor for RA

A

Ruxolitinib (Jakafi)

39
Q

a JAK1/JAK2 inhibitor for RA

A

Baricitinib (Olumiant)

40
Q

JAK3 inhibitor for moderate to severe RA not responding to methotrexate

A

Tofacitinib (Xeljanz)

41
Q

gout pathophysiology

A
  • chronic disease
  • biochemically: a disorder of uric acid metabolism
  • clincially: hyperuricemia & recurrent attacks of acute arthritis caused by deposition of crystals of sodium urate in tissues, especially joints and the kidney.
42
Q

____________ is the end product of purine metabolism and is poorly soluble, especially in acid environments.

A

uric acid

43
Q

where is gout usually found

A

joint of the big toe

44
Q

what does deposition of crystals of sodium urate in the tissues, joints and kidneys cause

A

acute inflammatory reactions, and tophi or inflamed swellings

45
Q

When blood uric acid level becomes saturated…

A

neutrophils phagocytize the crystals.

46
Q

when crystals are phagocytized by neutrophils, they fuse with…

A

lysosomes

47
Q

lysosomes eventually rupture and cause the cell to lyse, releasing

A

lysosomal enzymes and inflammatory and chemotactic mediators such as PGs, IL-1, and lactate (which decreases pH, so solubility of urate decreases - vicious cycle!).

48
Q

PGs, IL-1, and lactate attract….

A

PMNs (polymorphonuclear neutrophils) to the site.

49
Q

causes for both hyperuricemia and acute arthritic episodes

A
  • drug effects
  • renal damage
  • metabolic
  • increased nucleic acid turnover
  • enzyme defect
  • local decrease in urate solubility
  • increased urate production
50
Q

drug therapy for gout
2 primary aims

A

prevent/reduce the inflammation & pain of the acute attack

reduce blood urate levels (<6 mg/dl); increase urate excretion or decrease production.

51
Q

dietary changes for gout

A

reduce amount of purines in diet

52
Q

non pharm treatment for gout

A

dietary changes
weight reduction
adequate fluid intake
limit ETOH consumption

53
Q

Drugs that Increase Urate Excretion (uricosurics):

A

Probenecid

54
Q

Drugs that Decrease Uric Acid Production:

A

Allopurinol (Zyloprim)

Febuxostat (Uloric)

55
Q

what drug is an alkaloid of Colchicum autumnale (autumn crocus, meadow saffron)

A

Colchicine

56
Q

mechanism of action of colchicine

A
  • Binds to tubulin & disrupts mitotic spindles
  • causes depolymerization
  • affects microtubules in granulocytes & inflammatory cells; cannot migrate to the inflamed area
57
Q

the net effect of colchicine in gout attacks

A

is to decrease release of lactic acid

58
Q

colchicine uses

A

Effective at the onset of symptoms and gives prompt relief

59
Q

How fast does colchicine reduces symptoms of gout?

A

within 12 hours (pain, swelling, redness)

symptoms completely gone within 48-72 hrs

60
Q

colchicine is also useful as…

A

a prophylactic agent in very low doses at the initiation of treatment with other anti-gout drugs to decrease risk of acute attacks of gout (0.5 mg 2-4 times/wk).

61
Q

what happens with colchicine causing the cessation of mitotic spindle formation

A
  • mitosis is arrested at metaphase
  • affects cells with high division rates (rapidly proliferating cells of the GI tract)
62
Q

GI symptoms with colchicine

A

nausea, vomiting, abdominal pain, and diarrhea in 80%

63
Q

a serious symptom of colchicine OD

A

hemorrhagic gastroenteritis

64
Q

if colchicine is not stopped after patient experiences hemorrhagic gastroenteritis what may occur

A

can progress to vascular damage, renal toxicity, muscular depression (kills muscle cells), and paralysis (CNS mediated).

65
Q

how is colchicine administered

A
  • PO (pushing the dose until pain relief or diarrhea)
  • IV (works faster and can avoid GI side effects)
66
Q

extravasation with colchicine can cause

A

severe tissue necrosis

67
Q

Although colchicine can arrest cell division, effects on ____________ , etc. are not common problems with usual therapeutic doses (but may be seen with long term use).

A

bone marrow, gonads

68
Q

colchicine can be used with what other drugs

A

probenecid and allopurinol.

69
Q

____________ is marketed in several combination products with probenecid.

A

colchicine

70
Q

NSAID of choice in acute gout attack

A

indomethacin

71
Q

with NSAIDS, the inhibition of ____________ by these drugs accounts for many of their clinical effects on inflammation and pain

A

prostaglandin synthesis

72
Q

steroid use in acute gout attacks

A

these drugs accounts for many of their clinical effects on inflammation and pain

73
Q

probenecid mechanism of action

A

blocks reabsorption of urate in the renal proximal tubule.

Also blocks urate secretion, but effects on reabsorption predominate and the net result is increased urate excretion in urine - a uricosuric effect.

Uricosuric

74
Q

____________ is the prototype inhibitor of organic anion secretion (used to increase t1/2 of penicillin by decreasing its secretion).

A

probenecid

75
Q

when used in sufficient amounts, ____________ interferes with uric acid reabsorption.

A

probenecid

76
Q

when using probenecid with uricosuric agents, there is a ____________ effect

A

paradoxical

77
Q

paradoxical effect of using probenecid with uricosuric agents

A

small doses can compete with uric acid for tubular secretion and occasionally may even increase serum uric acid concentration.

78
Q

initiation of probenecid therapy may precipitate…

A

an acute gout attack

79
Q

prophylactic use of ____________ can prevent the acute attack

A

colchicine or an NSAID

80
Q

It is best not to start treatment with a uricosuric until ____________ after an acute gout attack.

A

1-2 weeks

81
Q
A